| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |